Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 64 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PiotFarma from Tielt-Winge, company number BE0767724217, closed financial year 2025 with a result of € 28,977 after tax. For that financial year PiotFarma recorded a gross margin of € 310,508 and equity of € 10,000. Compared with financial year 2024, the result moved from € -101,860 to € 28,977. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 10,000
▼ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 28,977
▲ still € 101,860 loss in 2024
Profit after tax over the fiscal year.
€ 175,471
▲ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 31,737 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
0.9
▲ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 88,572
▲ 47% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 39,932
▲ 11% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.4 million
▼ 18% vs 2024
€ 128,164 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 81,073
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 34,952
▲ 37% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 211,119 | € 113,163 | € 235,615 | € 310,508 | ▲ 32% |
| Profit after taxes | € 80,421 | € 24,199 | € -101,860 | € 28,977 | ▲ € 130,837 |
| Equity | € 90,421 | € 114,620 | € 12,760 | € 10,000 | ▼ 22% |
| Total debts | € 165,228 | € 218,921 | € 1,852,669 | € 1,544,001 | ▼ 17% |
| Cash | € 74,432 | € 94,158 | € 125,406 | € 175,471 | ▲ 40% |
| Retained profit | € 80,421 | € 104,620 | € 2,760 | € 0 | ▼ 100% |
| Dividend | € 0 | € 0 | € 0 | € 31,737 | |
| Bank debt | € 130,000 | € 171,803 | € 1,691,031 | € 1,379,911 | ▼ 18% |
| Balance sheet total | € 1,465,623 | € 1,549,201 | € 1,865,429 | € 1,785,706 | ▼ 4% |
| Employees (FTE) | - | - | 0.6 | 0.9 | ▲ 0.3 |
Key figures of PiotFarma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PiotFarma?
What happened at PiotFarma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 28,977. Source: NBB ↗
- New establishment in Tielt-Winge. KBO
- Start of the company according to the CBE. KBO
In short
From € 80,421 profit in 2022 to € 28,977 profit in 2025.
Paid € 55,520 in corporate taxes since 2022.
Best year ever: 2022, with € 80,421 profit.
Paid out € 31,737 in dividends to the owners in total.
Management
Behind PiotFarma are Jonas Piot, Hans Piot and Greet Tambeur. Hans Piot is also behind Apotheek Tambeur. Greet Tambeur is also behind Apotheek Tambeur.
Directors
According to the 2025 annual accounts
Jonas Piot
Director
Establishments
Establishment units
Physical locations of this company
Blerebergstraat 16
3390 Tielt-Winge
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0767.724.217
- VAT number
- BE 0767.724.217
- Registered office
- Blerebergstraat 16, 3390 Tielt-Winge
- Names & denominations
- PiotFarma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 April 2021
- Peppol
- Active · Active since 18 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Holdings
Overige zakelijke dienstverlening, neg